JESSICA PURDOM: Open Payments
NPI 1932430394 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,521 in 69 payments from 32 companies in 2025. Trend: 2023 $1,446 · 2024 $1,223 · 2025 $3,521
Food & beverage: $1,995Honoraria: $980Travel & lodging: $545
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. | 6 | $1,839 |
| Janssen Biotech, Inc. | 9 | $232 |
| Regeneron Healthcare Solutions, Inc. | 4 | $203 |
| Novartis Pharmaceuticals Corporation | 6 | $150 |
| AstraZeneca Pharmaceuticals LP | 5 | $142 |
| Merck Sharp & Dohme LLC | 4 | $120 |
| ABBVIE INC. | 3 | $65 |
| Gilead Sciences, Inc. | 2 | $59 |
| Daiichi Sankyo Inc. | 2 | $55 |
| JAZZ PHARMACEUTICALS INC. | 2 | $48 |
Products named: CABOMETYX, LIBTAYO, KISQALI, KEYTRUDA, RYBREVANT, Trodelvy, Enhertu, ZEPZELCA.
Industry payments across TN — which companies pay providers there.
